Majid Moshirfar, MD
Ophthalmology · Salt Lake City, UTNPI 1700976313
Payments from drug & device makers
Across 189 payments — averaging $7186.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$467K
- AbbVie$379K
- Alcon Research LLC$294K
- Rxsight Inc$103K
- Glaukos Corporation$60K
- Avedro Inc.$48K
- plus $7K from 13 others
Across 1 payment — averaging $4400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Surgical Vision, Inc.$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 56 | $467,018 |
| AbbVie(2 entities) | 34 | $378,785 |
| Alcon Research LLC | 4 | $293,933 |
| Rxsight Inc | 10 | $102,908 |
| Glaukos Corporation | 58 | $60,267 |
| Avedro Inc. | 1 | $48,320 |
| Leica Microsystems Inc. | 1 | $2,750 |
| Beaver-visitec International, Inc. | 1 | $2,500 |
| Alcon | 12 | $1,297 |
| Johnson & Johnson Vision Care, Inc. | 1 | $209 |
| Haag-streit USA, Inc. | 1 | $42 |
| Biotissue Holdings Inc. | 2 | $38 |
| Dompe US, Inc. | 2 | $33 |
| Ocular Therapeutix, Inc. | 1 | $20 |
| Ivantis, Inc | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Carl Zeiss Meditec USA, Inc. | 1 | $17 |
| Tarsus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,358,206 in reported general payments places this provider in the 95th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Salt Lake City
- Iqbal AhmedSalt Lake City$1.1M
- Zachary ZavodniSalt Lake City$1.1M
- Paul BernsteinSalt Lake City$354K
- Craig ChayaSalt Lake City$234K
- Robert CionniSalt Lake City$191K
- Kristin BretzSalt Lake City$175K
- Stacy SmithSalt Lake City$166K
- Marc Steffen Schmitz-ValckenbergSalt Lake City$160K
- Rachel SimpsonSalt Lake City$135K
- Rachael JacobySalt Lake City$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.